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Background: In previous works we have shown that a low-molecular-mass (LMM) fraction from mushroom
(Lentinus edodes) homogenate interferes with binding of Streptococcus mutans to hydroxyapatite and Prevotella
intermedia to gingival cells. Additionally, inhibition of biofilm formation of both odonto- and periodonto-pathogenic
bacteria and detachment from preformed biofilms have been described for this compound. Further purification of
mushroom extract has been recently achieved and a sub-fraction (i.e. # 5) has been identified as containing the
majority of the mentioned biological activities. The aim of this study was to characterise the bacterial receptors for
the purified mushroom sub-fraction #5 in order to better elucidate the mode of action of this compound when
interfering with bacterial adhesion to host surfaces or with bacteria-bacteria interactions in the biofilm state.
Methods: Candidate bacterial molecules to act as target of this compound were bacterial surface molecules
involved in cell adhesion and biofilm formation, and, thus, we have considered cell wall associated proteins (CWPs),
teichoic acid (TA) and lipoteichoic acid (LTA) of S. mutans, and outer membrane proteins (OMPs) and
lipopolysaccharide (LPS) of P. intermedia.
Results: Fifteen S. mutans CWPs and TA were capable of binding sub-fraction #5, while LTA did not. As far as P.
intermedia is concerned, we show that five OMPs interact with sub-fraction # 5. Capacity of binding to P. intermedia
LPS was also studied but in this case negative results were obtained.
Conclusions: Binding sub-fraction # 5 to surface molecules of S. mutans or P. intermedia may result in inactivation
of their physiological functions. As a whole, these results indicate, at molecular level, the bacterial surface alterations
affecting adhesion and biofim formation. For these antimicrobial properties, the compound may find use in daily
oral hygiene.
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Dental caries and gingivitis are two infectious diseases
affecting a worldwide population and are the result of
accumulation of the dental plaque, a polymicrobial bio-
film on both tooth and gum surfaces [1,2]. Caries results
from an acidic demineralisation of tooth hydroxyapatite
(HA) produced by specific odontopathogenic bacteria
(mainly Streptococcus mutans) in the presence of fer-
mentable carbohydrates e.g. sucrose. The role of sucrose
is fundamental in that it acts as substrate for a set of S.
mutans glucosy-transferases (GTFs) which polymerise
glucose from sucrose to a sticky exo-polysaccharide
(called mutan). Mutan allows bacteria to tightly adhere
to dental hydroxylapatite and, thus, to tooth surface. S.
mutans has an efficient sugar metabolism and produces
lactic acid (acidogenicity) with the additional capability
of surviving in an acidic environment (aciduricity). The
acid production is responsible for HA solubilisation, car-
ies initiation and progression. Gingivitis (gum inflamma-
tion) results from accumulation of a heterogeneous
subgingival plaque in which strict anaerobes dominate
[3,4]. Overgrowth of strict anaerobes causes production
of increased amounts of both bacterial toxins and catab-
olites. These are toxic for gingival cells and result in cell
death and tissue inflammation. Thus, inhibition or re-
duction of dental plaque accumulation by various means
is considered one of the best approaches to accomplish
an effective prevention of diseases [1,2].
Consumption of foods and beverages rich in sugars
coupled with poor oral hygiene are considered leading
causes of dental plaque overgrowth and accumulation.
During the past two decades several components of a
variety of common foods (mainly vegetables) have been
characterised by in vitro antibacterial and antiplaque as-
says and show potential anticaries and/or antigingivitis
activities see for recent reviews [5,6].
In previous work we has shown that low-molecular-
mass (LMM) fractions from either mushroom (Lentinus
edodes) or red chicory (Cichorium intybus) homogenates
(at sub-growth inhibitory concentration) interfere with
binding of S. mutans (the main etiological agent of the
dental caries) cells to HA and Prevotella intermedia (an
example of periodontopathogenic bacteria) cells to gin-
gival cells [7,8]. Additionally, biofilm formation of both
odonto- and periodonto-pathogenic bacteria and detach-
ment from preformed biofilms has been described for
the compounds mentioned above [8]. Further purifica-
tion of mushroom extract has been recently performed
and a sub-fraction (i.e. # 5) has been identified as con-
taining the majority of the biological activities [Papetti
et al., manuscript submitted]. Beside these observations,
the antimicrobial mode of action has been evaluated at
the minimal inhibitory concentration, and an antibiotic-
like mode of action have been described for the LMMfractions of both mushroom and chicory extracts. This
activity strongly inhibited DNA synthesis and partially
RNA synthesis with 50% reduction of protein synthesis
in both S. mutans and P. intermedia [9,10]. As result of
cell division (septum formation) inhibition, a certain de-
gree of cell elongation has been observed in S. mutans
(i.e. from ovoidal cells of the control to rod-like cells),
while P. intermedia elongated from rods to form fila-
ments. These morphogenetic effects are reminiscent of
those obtained by treatment with antibiotics such as β-
lactams or quinolones, two distinct families acting on
different targets but having in common the inhibition of
septum formation and, therefore the capability of fila-
ment formation [9,10].
The aim of this study was to characterise the bacterial
receptors for the purified mushroom sub-fraction #5 in
order to better elucidate the mode of action of these
compounds. More precisely when interfering with bac-
terial adhesion to host surfaces or with bacteria-bacteria
interactions when they are in the biofilm state. This is
with a view to develop reliable tools for screening new
natural compounds capable of binding (and inactivating)
bacterial target(s). Candidate bacterial molecules to act
as targets for these compounds are bacterial surface
molecules. We considered cell wall associated proteins
(CWPs), teichoic acid (TA) and lipoteichoic acid (LTA)
of S. mutans and outer membrane proteins (OMPs) and
lipopolysaccharide (LPS) of P. intermedia.
Methods
Strain used and growth conditions
S. mutans UA159 and P. intermedia ATCC 25611 were
used throughout this study. S. mutans cells were grown
in brain hearth infusion broth (BHIB) or on brain hearth
infusion agar (BHIA) (Oxoid Ltd, Basingstoke, England).
Cultures were incubated at 37°C in an atmosphere
enriched with 5% CO2 as previously described [10]. P.
intermedia was grown in BHIB to which 5 μg/ml haemin
and 1 μg/ml vitamin K (Sigma-Aldrich Co, St. Louis,
MO, USA) were added (BHIB + HK) or in Blood Agar
(BA, Oxoid) plates. Cultures in both liquid and solid
media were incubated at 37°C in an anaerobic chamber
(Whitley DG 250 Anaerobic Workstation, Don Whitley
Scientific, Shipley, UK) with an atmosphere composed of
85% nitrogen, 10% hydrogen and 5% CO2 [9].
Extraction of S. mutans cell wall associated proteins
(CWPs)
CWPs were extracted with 8 M urea as previously de-
scribed [11]. Briefly, 1 litre of an exponentially growing
culture of S. mutans (O.D. 540 nm 0.7 O.U.) was rapidly
chilled and cells collected by centrifugation (5,000 × g,
10 min) at 4°C. Cell pellet was extensively washed with
10 mM sodium phosphate buffer (pH 7.2), resuspended
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The extract was then dialysed against 10 mM sodium
phosphate buffer (pH 6.5) to remove urea and proteins
concentrated by 60% (saturation) ammonium sulphate
precipitation and finally dialysed against 20 mM sodium
phosphate buffer (pH 7.5) containing 1 mM phenyl-
methylsulfonyl fluoride. Protein concentration was de-
termined by the BioRad kit (BioRad Laboratories srl,
Segrate, Italy).
Extraction of S. mutans TA
TA were extracted with 5% trichloroacetic acid (TCA) as
previously described [12]. The pellet from one litre of an
exponentially growing culture obtained as above was twice
extracted with 5% TCA o/n at 4°C. Supernatants, after
centrifugation at 18,000 × g at 4°C, were pooled and TA
precipitated with 5 volumes (v/v) of absolute ethanol at
4°C for 16 h. Precipitated TA was collected by centrifuga-
tion at 18,000 × g at 4°C and resulting pellet washed twice
with ethanol and finally with diethylethere. TA was resus-
pended in 2 ml of double distilled water, neutralized and
concentration determined by estimating the organic phos-
phorus using the method of Chen et al. [13].
Extraction of S. mutans LTA
LTA was extracted from de-acetylated bacteria with the
hot phenol procedure essentially as described by Signor-
etto et al. [12]. Briefly, harvested bacteria from 1 litre
culture were treated twice with chloroform-methanol
(2:1 v/v) at RT for 2 h and then once with 45% aqueous
phenol at 68°C for 45 min with stirring. Phenol was re-
moved by dialysis against 0.1 M sodium acetate (pH 5.0).
Nucleic acids were, then, degraded by extensive treat-
ment with both DNase and RNase. Finally, additional
phenol extraction and extensive dialysis against 20 mM
sodium phosphate (pH 7.5) were performed to remove
nuclease proteins and nucleic acid fragments. The
resulting LTA was quantitated by measurement of phos-
phorus [13].
Extraction of P. intermedia OMPs
OMPs were extracted after selective removal of inner
membrane proteins as previously described [14]. An ex-
ponentially growing culture (1 litre, O.D.540 nm 0.3 O.
U.) was rapidly chilled and collected by centrifugation
as described above. Cells were disrupted by sonication,
unbroken cells removed by low-speed (2,000 × g) cen-
trifugation and, finally cell envelopes collected by ultra-
centrifugation (40,000 × g) for 60 min at 4°C. Inner
membrane proteins were removed by treatment with
1% Sarkosyl (Sigma-Aldrich) and 1 mM phenylmethyl-
sulfonyl fluoride for 1 hour at RT. After further ultra-
centrifugation, the resulting pellet was considered outer
membrane. OMPs were solubilised with 0.5% n-octyl-β-D-thioglucoside in 20 mM sodium phosphate buffer
(pH 7.5) and 1 mM phenylmethylsulfonyl fluoride for
2 h at RT. The supernatant after a further ultracentrifu-
gation was extensively dialysed against 20 mM sodium
phosphate buffer (pH7.5) to remove the n-octyl-β-D-
thioglucoside.
Extraction of P. intermedia LPS
LPS was extracted from whole cells using the procedure
described by Eidhin & Mouton [15]. This method allowed
water extraction of LPS at 100°C followed by digestion
with proteinase K. Finally, proteinase K was removed by
hot phenol treatment at 65°C and LPS lyophilized.
LMM fraction of mushroom extract
The LMM fractions (< 5,000 Daltons) of shiitake mush-
room (frozen shiitake mushroom Lentinus edodes was
purchased from Asiago Food SpA, Veggiano, Padua, Italy)
was prepared by ultrafiltration of the crude homogenate
using the Vivaflow 200 system (Vivascience AG, Hannover,
Germany) equipped with a membrane 5,000 MWCO PES
for ultradiafiltration, as described elsewhere [7]. About 70%
and 50% (w/w) of the components originally present in the
crude mushroom homogenate was detected in the ultradia-
filtrates. The ultradiafiltrates were sterilized using a 0.20 μm
pore size membrane (Vivascience), then freeze-dried and
stored up to 3 months at -80°C. Immediately before use, a
sample was rehydrated with sterile distilled water to obtain
a 10× solution and kept at 4°C for no longer than a week.
The 1× concentration of the LMM fraction after reconstitu-
tion represents the original concentration in the food.
Preparation and chemical characterization of
sub-fraction #5 from the LMM fraction of mushroom
extract
Sub-fraction # 5 was purified by gel filtration chro-
mathography (GFC) from a LMM fraction of mushroom
extract as previously described for Cichorium intybus
[16]. Briefly: GFC analyses were carried out on an Agi-
lent 1100 series liquid chromatography system (Agilent,
Waldbronn, Germany) equipped with a diode array de-
tector. The Agilent Chemstation software was used for
HPLC system control and data processing. A Merck
Superformance Universal glass cartridge system (300
mm × 10 mm) was used for GFC separation and the ana-
lyses were performed with a TSK gel Toyopearl HW-
40 F (exclusion limits 100–10000 Da; Tosoh Corporation,
Tokyo, Japan) with Millipore grade water as the mobile
phase, at a flow rate of 0.5 mL/min. UV spectra were re-
corded in the 190–600 nm range, and chromatograms
were acquired at 210 nm. Six fractions were collected and
sub-fraction #5 corresponded to the compounds eluting at
154.3 ± 0.5 min.
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terized by liquid chromatography with tandem mass spec-
trometry (LC–ESI/MS/MS). The analyses were performed
with a Gemini C18 analytical column (150 × 2.0 mm, i.d.,
5 lm; Phenomenex, Torrance, CA), connected to a Hyper-
sil Gold C18 guard column (10 × 2.1 mm i.d., 5 lm; Phe-
nomenex, Torrance, CA), with a binary mobile phase
methanol/water acidified with 0.1% formic acid 5/95 (v/v)
at a flow rate of 0.3 mL/min. Column and autosampler
temperatures were held constant at 4°C. Chromatograms
were recorded at 210 nm. Chemical characterization re-
vealed that sub-fraction #5 contains 11 sub-sub-fractions
mainly composed of quinic acid, uridine, adenosine, in-
osine, aconitic acid, oxalic acid and succinic acid.
Binding of sub-fraction #5 of LMM fraction of mushroom
extract to epoxy-activated Sepharose 6B
Epoxy-activated Sepharose 6B resin (Sepharose, Sigma-
Aldrich) was chosen for the diversity of chemical groups
of the ligands (hydroxyl, amino, thiol) that can be involved
in resin coupling. In addition, resin has long hydrophilic
spacer arm which make it particular suitable for
immobilization of small molecules such as those included
in sub-fraction # 5. Preparation of the resin for binding
the sub-fraction # 5 as well as de-activation of the
remaining active groups after coupling was performed ac-
cording to manufacturers instructions. Finally, coupled
resin was stored in 20 mM sodium phosphate buffer
(pH 7.5) with 0.05% sodium azide. The amount of the
phenolic compounds bound to the resin was determined
by the Folin-Ciocalteu method (Sigma-Aldrich). The spe-
cificity of binding of the bacterial surface molecules was
determined by preparing a resin sample which was de-
activated prior binding the sub-fraction #5.
Binding to and detachment from the conjugated resin of
the specific bacterial macromolecules
S. mutans CWPs and P. intermedia OMPs were mixed
with 1 g of sub-fraction #5 coupled resin in 30 mM so-
dium phosphate buffer containing 20 mM CaCl2
(pH 7.5) and 0.05% sodium azide at 37°C for 2 h. Then,
unbound proteins were removed by extensive washing of
the conjugated resin with 50 mM phosphate buffer
(pH 7.5). Detachment of proteins that specifically bound
sub-fraction #5 was performed by adding 2% SDS and
heating at 100°C for 5 minutes. Finally, proteins were vi-
sualized by 10% SDS-PAGE [17], coloured by silver
staining (Bio-Rad Laboratories).
P. intermedia LPS in lyophilized form was resus-
pended in 30 mM sodium phosphate buffer containing
20 mM CaCl2 (pH 7.5) and 0.05% sodium azide and put
in contact with the coupled resin at 37°C for 2 h. Resin
was extensively washed with the same buffer and bound
LPS was detached by adding 2% SDS and heating at100°C for 5 minutes. Finally, LPS was visualized by
12.5% SDS-PAGE [17].
S. mutans TA or LTA was resuspended in neutralised
distilled water and put in contact with the coupled resin
at 37°C for 2 h. Resin was extensively washed with dis-
tilled water and bound TA was finally detached with 5%
potassium persulfate at 120°C for 30 min. The amounts
of bound TA or LTA were determined with by measure-
ment of phosphorus [13].
Three replicate bindings were performed with two dis-
tinct preparations for all the bacterial surface molecules
tested with very similar results.
Results
Coupling of the mushroom sub-fraction #5 to the resin
Epoxy-activated Sepharose 6B was chosen because of its
ability to bind covalently hydroxyl-groups of several com-
pounds contained in sub-fraction #5 of LMM fraction of
mushroom extract. The protocol allowed us to bind 30
μmoles of phenol sub-fraction per ml of drained resin.
Furthermore, de-activation of the active groups of the
resin prior binding sub-fraction #5 allowed determination
of the specificity of the further binding of the bacterial
surface molecules tested. In this case no amount of sub-
fraction #5 was bound to the resin as evaluated by phenol
determination and, consequently, no bacterial surface
molecule was bound (data not shown).
Identification of S. mutans surface macromolecules acting
as receptors of mushroom subfraction #5
Figure 1 shows a typical electropherogram of the S.
mutans CWPs where 16 protein bands are visible. Based
on their electrophoretic mobility, these CWPs have been
identified after sequencing the entire S. mutans genome
[18]. Figure 1 and Table 1 show that 15 of the 16 CWPs
were capable of binding sub-fraction #5, with only FruA
(M.W. 158,530) unbound.
Table 2 shows the results of representative experi-
ments of the binding of TA or LTA to sub-fraction #5: it
shows that only TA had this capability, while LTA did
not bind. Three binding attempts with each of two dis-
tinct LTA preparations were performed with very similar
results.
Identification of P. intermedia surface molecules acting as
receptors of mushroom subfraction #5
Figure 2 shows a SDS-PAGE of the OMPs of P. inter-
media. As expected a small number of protein bands
(about a dozen) are shown in comparison to the whole
proteome [19], however, when evaluated, only five pro-
teins were detected capable of binding sub-fraction #5.
Their approximate M.W. were 57, 51, 46, 36 and 33 KD.
As far as the binding of LPS is concerned, Figure 3





















Figure 1 Total cell wall proteins (CWPs) of S. mutans (A) and
CWPs bound by sub-fraction #5 (B) separated by SDS- PAGE.
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with two separate preparations. It is worthy of note that
P. intermedia ATCC 25611 is a “rough” strain (i.e.
endowed with a LPS composed by lipid A plus core
only), thus, in order to evaluate whether the absence ofO chain could affect the binding to sub-fraction #5, we
have used a commercially available E. coli O127:B8
(ATCC 12740) LPS (Sigma-Aldrich) purified from a
smooth strain to try binding. In this case a positive re-
sult was obtained (data not shown).
Discussion
Although foods and beverages and oral hygiene practices
are still currently considered major contributors to oral
infectious diseases such as caries and gingivitis/peri-
odontitis, specific foods and beverages have been dem-
onstrated to exert antimicrobial, antiadhesive and
biofilm disgregating activities [5,6]. Among the numer-
ous potentially active foods, fractions of them and iden-
tified bioactive compound(s), we have previously
identified a LMM fraction of shiitake mushroom aque-
ous extract with promising properties [7,8]. This LMM
fraction has been further fractionated and the best
in vitro biological activities demonstrated to be associ-
ated with sub-fraction #5. [Papetti et al., manuscript in
preparation].
S. mutans and P. intermedia, were chosen as appropri-
ate representatives of disease; being an etiological agent of
dental caries and a representative of the bacterial complex
involved in gingivitis and later in progression to periodon-
titis, respectively. These were coupled with relevant assays
which included inhibition of adhesion, inhibition of bio-
film formation and biofilm disruption [16].
Because a main target of the bioactive compound(s) is
the adhesion of bacteria to abiotic or biotic surfaces and
with cell-cell interaction as in the case of biofilm forma-
tion, the aim of this work was to evaluate which bacter-
ial surface molecules were targeted by the bioactive
compounds. To do this, candidate bacterial surface com-
pounds CWPs, TA and LTA in the case of S. mutans
and OMPs and LPS of P. intermedia were prepared and
used to characterise sub-fraction #5.
As far as S. mutans was concerned, 15 out 16 CWPs
were bound by sub-fraction #5; this implies that the sub-
fraction may play an important, but complex, role in
inhibiting bacterial cell adhesion and biofilm formation.
SpaP, the surface protein antigen A also known as pro-
tein I1, antigen B, Pac, SR and antigen I/II is a well char-
acterised adhesin of S. mutans. Gene cloning and
sequencing [20] has revealed a block of alanine-rich re-
peats and another of proline-rich repeats which are im-
plicated in binding to salivary agglutinin glycoprotein
gp340, a protein involved in saliva-mediated aggregation
and adherence [21]. Importantly, antibody raised against
SpaP blocked attachment of S. mutans to saliva-coated
hydroxyapatite [22]. Sub-fraction #5 could act similarly.
Wall associated protein WapA or Antigen III is released
in the growth medium in a 29 KDa form although its
gene encodes for a protein of 48,769 KDa. Knockout of
Table 1 S. mutans UA159 CWPs capable of binding sub-fraction #5
Band no.a Approx. M.W.b Binding to sub-fraction #5 Putative protein identificationc Sequence-deduced M.W.c
1 170 KD Yes SpaP 168,841
2 155 KB No FruA 158,530
3 115 KD Yes AtlA 107,062
4 91 KD Yes dexA 94351
5 83 KD Yes GbpD 79,656
6 66 KD Yes GbpC 63,219
7 64 KD Yes SMU 1449 63,011
8 62 KD Yes GbpA 62,997
9 57 KD Yes Putative surface adhesin 57,392
10 50 KD Yes WapA 48,769
11 46 KD Yes GbpB 44,489
12 45 KD Yes GtfS 44,429
13 40.5 KD Yes RgpG 42,470
14 36 KD Yes GapC 35,937
15 33 KD Yes SloC 34,234
16 27 KD Yes StrA 27,342
aAs specified in Figure 1.
bDetermination based on electrophoretic mobility.
cAccording to the global sequence of S. mutans UA159 genome [18].
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face ultrastructure and biofilm formation [23]. WapE ap-
pears to alter cell surface and biofilm formation [18,24].
Glucan binding protein (Gbp) A, B, C and D are media-
tors of the sucrose-dependent adherence of S. mutans to
polymers formed from sucrose. GbpA and GbpD con-
tain a series of repeats (glucan binding domains) similar
to those found in glucosyl transferases (GTFs) and, in
addition to this, GbpD contains a lipase activity [25]. In
vitro testing of knockouts of either GbpA or GbpD re-
sults in altered biofilm architecture suggesting a funda-
mental role in dental plaque structure [26]. GbpB and
GbpC lack the repeats characteristic, sharing GbpB se-
quence homology with putative peptidoglycan hydro-
lases of other streptococci, thus hypothesizing a crucial
role in cell wall turnover and stress response [27]. GbpC
binds dextran tightly and, for this reason, is considered
the major receptor involved in dextran-dependent aggre-
gation, a mechanism involved again in biofilm architec-
ture [26]. AtlA is a surface-associated protein that plays
a critical role in surface biogenesis, biofilm formation,
genetic competence and autolysis [28]. SloC, a cell wall
associated component of the complex SloABC, is aTable 2 Amount of S. mutans UA159 TA and LTA bound
by sub-fraction #5
Macromolecule Total (mg/L) Bound (mg/L)a Bound (%)a
TA 28.9 23.8 ± 1.12 82.35 ± 4.49
LTA 38.3 0.11 ± 0.01 0.28 ± 0.002
a Values are the means ± SD of three distinct binding experiments.solute-binding lipoprotein and a metal-dependent regu-
lator which is involved in manganese and iron transport,
thus regulating virulence gene expression of S. mutans
[29,30]. SrtA or sortase is a transpeptidase that cova-
lently links LPXTGX-containing surface proteins to the
Gram-positive bacterial cell wall, included S. mutans.
The S. mutans SrtA mutant is markedly less hydropho-
bic than wild-type, non adherent to hydroxyapatite, non
aggregating in the presence of saliva and salivary agglu-
tinin. Thus, sortase plays a crucial role in the surface-
related properties by modulating the bacterial cell sur-
face [31]. RgpG protein is involved in the synthesis of S.
mutans rhamnose-glucose polysaccharide [32]. Although
the mechanisms of cell surface polysaccharide synthesis
are poorly characterized in Gram-positive bacteria, it is
however clear that polysaccharides play crucial role in
cell wall architecture and bacterial virulence [33]. DexA
is a dextranase which can partially degrade glucan and,
thus may affect S. mutans virulence [34]. GapC, an
extracellular glyceraldehyde-3-phosphate, is involved in
acid production from glucose [35]. Interestingly, inhib-
ition of glycolysis by chlorexidine was demonstrated at
GapC level [36].
It is known that polyphenols are capable of protein
binding with high affinity and denaturation [37,38]. In
this study we have shown for the first time that these
polyphenol properties are expressed against proteins
fundamentally involved in cell adhesion, biofilm forma-














Figure 2 Total outer membrane proteins (OMPs) of P. intermedia




Figure 3 P. intermedia LPS (A) and LPS bound by sub-fraction
#5 (B) visualized in SDS- PAGE.
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several CWPs involved in S. mutans adhesion and bio-
film formation, TA has been shown to be bound by sub-
fraction #5. This takes into account the biological role
played by TA in cell wall structure of Gram-positive bac-
teria, an effect of disorganizing this fundamental bacter-
ial structure may be suggested. On the contrary, purified
LTA, at least in the experiments we performed, was un-
able to bind sub-fraction #5 and this may caused by the
lipid moiety rather than the polysaccharide chain. It maybe that in growing bacteria, since the lipid moiety is in-
cluded in the cytoplasmic membrane and the polysacchar-
ide component is included in the width of the cell wall,
sub-fraction #5 may interact with this macromolecule.
If this were true, since LTA is involved in bacterial
adhesion to both biotic and abiotic surfaces, further in-
hibition of this fundamental virulence property may
occur.
As far as P. intermedia is concerned, we have evaluated
the binding capability of the OMPs, showing that a few
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mental roles in Gram-negative bacteria functioning as a
dynamic interface between the cell and the surrounding
environment. Functions of these proteins include main-
taining of cell structure, passive and active transport, ad-
hesion to other cells, and binding a variety of substances
[39]. Although studied to a lesser extent than those of
Gram-negative facultative bacteria such as E. coli, similar
functions can be attributed to the OMPs of Gram-
negative anaerobes [19,40]. As in the case of S. mutans,
binding sub-fraction #5 to surface proteins of P. inter-
media may result in denaturation and inactivation of their
physiological functions. This is compatible with the ob-
served intererence of P. intermedia adhesion to gingival
cells [8,41], biofilm formation and disgregation [8].
Capacity of binding sub-fraction #5 to P. intermedia
LPS was also studied but in this case negative results
were obtained. This event, however, may be justified by
the fact that P. intermedia strain ATCC 25611 is a rough
strain, i.e. containing a LPS composed only by lipid A
and core but without a polysaccharide chain. Conse-
quently, lipid alone is incapable of binding. Support of
this statement comes from the observation that a com-
mercially purchased LPS purified from an E. coli smooth
strain, containing the polysaccharide O chain, is capable
of binding sub-fraction #5. It is concluded, thus, that
LPS may represent a target bacterial structure only in
smooth strains. It is worthy of note to recall, however,
that other major bacterial receptors may not be excluded
and have been not tested.
Experiments performed more recently have shown
that sub-fraction #5 contains 11 sub-sub-fractions
mainly composed of quinic acid, uridine, adenosine, in-
osine, aconitic acid, oxalic acid and succinic acid [Papetti
et al, manuscript in preparation] and biological activity
relies mainly in quinic acid (QA). Very recently Papetti
et al. [16] have shown that QA present in Cychorium
intybus is one of the most active compounds capable of
inhibiting virulence-related properties of oral pathogenic
bacteria.
Conclusion
This report suggests that, QA appears as a potential can-
didate to be used as active ingredient of products for
daily oral hygiene. The advantage of natural molecules is
that they comply with consumer’s demand for natural
constituents of drugs and disinfectants.
Finally, the discovery of bacterial targets for the action
of such compounds may allow us to set-up a simple la-
boratory method for selecting new natural compounds
capable of binding and inhibiting the physiological func-
tion(s) of these bacterial surface molecules. This is an
approach included in the so-called “antivirulence ther-
apy” [6].Competing interests
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